MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 21.03.2026
Sundial Growers EBITDA per Share 2011-2026 | SNDL
EBITDA per Share Jährlich Sundial Growers
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | -71 | -0.85 | -0.61 | - | - | - | - | - | - | - | - |
Alle Zahlen in CAD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.61 | -71 | -24.2 |
EBITDA per Share anderer Aktien in der Arzneimittelhersteller
| Name | EBITDA per Share | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
-0.32 | - | 7.5 % | $ 6.35 M |  USA |
 |
Alimera Sciences
ALIM
|
0.27 | - | - | $ 142 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
-0.86 | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
-9.17 | - | 10.11 % | $ 58.2 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-0.16 | - | 0.86 % | $ 117 M | USA |
 |
Aurora Cannabis
ACB
|
-1.67 | $ 3.27 | -1.36 % | $ 86.3 M |  Canada |
 |
China Pharma Holdings
CPHI
|
-0.11 | $ 0.63 | - | $ 11 M |  China |
 |
Catalent
CTLT
|
-1.44 | - | - | $ 11.5 B | USA |
 |
Athenex
ATNX
|
-10 | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-0.42 | - | - | $ 2.06 B |  France |
 |
Cronos Group
CRON
|
-0.504 | $ 2.52 | -0.2 % | $ 1.31 B | Canada |
 |
DURECT Corporation
DRRX
|
-1.4 | - | - | $ 50.1 M | USA |
 |
Emergent BioSolutions
EBS
|
-11.7 | $ 7.93 | -1.49 % | $ 406 M | USA |
 |
Endo International plc
ENDP
|
1.3 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
-2.22 | - | - | $ 36.6 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-10.3 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
-0.67 | - | 2.45 % | $ 38.1 M | Canada |
 |
Cumberland Pharmaceuticals
CPIX
|
0.22 | $ 3.06 | 0.33 % | $ 43 M | USA |
 |
Bausch Health Companies
BHC
|
6.1 | $ 4.97 | -2.74 % | $ 1.81 B | Canada |
 |
Harrow Health
HROW
|
0.87 | $ 34.8 | 2.35 % | $ 1.28 B | USA |
 |
OptiNose
OPTN
|
-0.2 | - | - | $ 1.08 B | USA |
 |
Evolus
EOLS
|
-0.39 | $ 4.55 | -2.78 % | $ 293 M | USA |
 |
Pacira BioSciences
PCRX
|
0.12 | $ 22.44 | -0.93 % | $ 1.04 B | USA |
 |
Eagle Pharmaceuticals
EGRX
|
6.31 | - | -39.89 % | $ 27.7 M | USA |
 |
Relmada Therapeutics
RLMD
|
-1.5 | $ 6.05 | 3.24 % | $ 239 M | USA |
 |
Rockwell Medical
RMTI
|
-0.22 | $ 1.04 | 1.96 % | $ 24.3 M | USA |
 |
Solid Biosciences
SLDB
|
-2.03 | $ 6.9 | -3.36 % | $ 604 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
-2.88 | $ 2.37 | -6.89 % | $ 2.94 M | USA |
 |
OrganiGram Holdings
OGI
|
-0.36 | $ 1.36 | -0.37 % | $ 402 M | Canada |
 |
PetIQ
PETQ
|
2.8 | - | 1.64 % | $ 400 M | USA |
 |
PLx Pharma
PLXP
|
-1.72 | - | -27.8 % | $ 2.56 M | USA |
 |
ProPhase Labs
PRPH
|
1.79 | - | - | $ 5.07 M | USA |
 |
Tilray
TLRY
|
-2.22 | $ 6.38 | -1.16 % | $ 3.94 B | Canada |
 |
Jupiter Wellness
JUPW
|
0.01 | - | - | $ 33.6 M | USA |
 |
Radius Health
RDUS
|
-1.13 | - | - | $ 1.42 B | USA |
 |
Lannett Company
LCI
|
-3.52 | - | 1.15 % | $ 7.11 M | USA |
 |
Veru
VERU
|
-0.27 | $ 2.29 | -0.43 % | $ 309 M | USA |
 |
Viatris
VTRS
|
2.92 | $ 13.33 | 0.3 % | $ 16 B | USA |
 |
SCYNEXIS
SCYX
|
-0.32 | $ 0.89 | 1.24 % | $ 44.4 M | USA |
 |
TherapeuticsMD
TXMD
|
-0.73 | $ 2.35 | 1.73 % | $ 24.5 M | USA |
 |
cbdMD
YCBD
|
-0.66 | $ 0.78 | 2.52 % | $ 3.36 M | USA |
 |
Organogenesis Holdings
ORGO
|
0.09 | $ 2.4 | -2.63 % | $ 316 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
-106 | - | - | $ 193 M | Canada |
 |
Perrigo Company plc
PRGO
|
-5.67 | $ 9.56 | -0.16 % | $ 1.32 B | USA |
 |
Assertio Holdings
ASRT
|
1.32 | $ 14.96 | 6.86 % | $ 95.8 M | USA |
 |
Canopy Growth Corporation
CGC
|
-0.89 | $ 0.95 | -1.54 % | $ 102 M | Canada |
 |
Recro Pharma
REPH
|
0.05 | - | -4.76 % | $ 65.3 M | USA |
 |
Tricida
TCDA
|
-2.97 | - | - | $ 3.25 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-0.82 | - | - | $ 55.5 M | USA |